Physician profile
Visoth Chan
NPI 1669716791
$1,952.55
in general payments reported to CMS, 2019-2025
25 companies · $492 in 2025
The $492 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $111 · 2021: $196 · 2022: $229 · 2023: $384 · 2024: $270 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,058 · Education: $87.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,058.25 |
| Education | $87.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $446.46 | 2019-2025 | Prophecy, Prostep, Prostep Mica |
| Smith+Nephew, INC. | $192.57 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Renasys Touch, Pico 7 |
| Tactile Systems Technology INC | $171.35 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Averitas Pharma INC. | $159.80 | 2024-2025 | Qutenza |
| Medtronic, INC. | $141.06 | 2023 | Intellis Adaptivestim |
| Sandoz INC. | $120.86 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $114.51 | 2024-2025 | Nuzyra |
| Djo, LLC | $107.95 | 2022 | |
| Biotissue Holdings INC. | $85.77 | 2024-2025 | |
| Inari Medical, INC. | $58.86 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mimedx Group, INC. | $51.90 | 2025 | |
| Integra Lifesciences Corporation | $40.31 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Aroa Biosurgery Incorporated | $30.51 | 2024 | |
| Medline Industries Lp | $29.28 | 2023 | |
| Depuy Synthes Sales INC. | $26.67 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $23.35 | 2021 | |
| Ermi LLC | $19.69 | 2019 | |
| Arteriocyte Medical Systems, INC. | $17.86 | 2024 | Magellan |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.56 | 2023 | Jublia |
| Saxum Surgical, INC. | $17.35 | 2025 | |
| Trevena, INC. | $17.30 | 2021 | |
| Pfizer INC. | $17.13 | 2019 | |
| Abbott Laboratories | $17.10 | 2023 | Eterna |
| Zimmer Biomet Holdings, INC. | $13.78 | 2019 | |
| Wright Medical Technology, INC. | $13.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Visoth Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.